📰 Statistical Methodology News
Page 3 - Statistical Methodology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statistical Methodology. Real-time updates on events, politics, business and more.
February 8, 2022
Join the Centre for Statistical Methodology for the first in a seminar series.
February 1, 2022
NSFs mission is to advance the progress of science, a mission accomplished by funding proposals for research and education made by scientists, engineers, and educators from across the country.
May 27, 2021
Centre for Statistical Methodology seminar series - missing data and causal inference theme There is an increased awareness of the importance of non-parametrically defining the causal effect measure of interest prior to any modelling of the data. This is relatively easily done when the exposure is binary, but much less straightforward when continuous exposures are considered.
May 26, 2021
As the final article in a three-part series that summarizes the discussions and exchanges of a BioPhorum Development Group workstream on small-scale...
March 16, 2021
Growth has consistently remained a central topic in economic policy considerations of the government in India. However, there has also been a more scholarly interest in it among social scientists. As a part of the latter tradition, this paper addresses the proper delineation of the phases of growth in India, a matter of some discussion in the literature. Using state-of-the-art
March 8, 2021
KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the bodys immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2 KIRKLAND, QC, March 8, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Health Canada has approved KEYTRUDA ® (pembrolizumab), Mercks anti-PD-1 therapy, for the first...
March 8, 2021
Approval Based on Significant Progression Free Survival Findings from Phase 3 KEYNOTE-177 Trial KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the body’s immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2 Merck known as MSD outside the United States … Approval Based on Significant Progression Free Survival Findings from Pha...
March 4, 2021
Southampton ranks top 50 globally for Statistics & Operational Research for a second year running. Southampton’s global ranking for Statistics & Operational Research has risen again this year, reaching 33rd – an improvement of 4 places on last year – in the QS World University Rankings by Subject for 2021. Southampton, which is ranked seventh by QS amongst UK universities listed in this subject area, not only improved its ranking for Statistics & Operational Research this year but also it...
June 24, 2012
does work. meet the president of a country where austety led to growth. finally, fidel castro on yoga. really. first here is my take. its hard to find any good economic news these days. europe is teetering on the brink, emerging markets like china, brazil and india are slowing down and the united states is in a slump. let me try to cheer you up. the cost of sequencing a human genome is down to $1,000 and it takes two hours. that is an acceleration of capacity that is faster, much f...